Serum ghrelin levels but not GH, IGF-1 and IGFBP-3 levels are altered in patients with fibromyalgia syndrome

Joint Bone Spine

Volumn 74, Issue 5, 2007, Pages 477-481

  Tander, Berna ^a   Atmaca, Aysegul ^b   Aliyazicioglu, Yuksel ^b   Canturk, Ferhan ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b ONDOKUZ MAYIS UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Fibromyalgia; Ghrelin; Growth hormone; Insulin like growth factor binding protein 3; Insulin like growth factor 1

Indexed keywords

C PEPTIDE; GHRELIN; GLUCOSE; GROWTH HORMONE; INSULIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEPRESSION; FEMALE; FIBROMYALGIA; GLUCOSE BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INSULIN BLOOD LEVEL; PAIN ASSESSMENT; PREMENOPAUSE; QUESTIONNAIRE; SLEEP DISORDER; VISUAL ANALOG SCALE;

ADULT; BODY MASS INDEX; C-PEPTIDE; DEPRESSION; FEMALE; FIBROMYALGIA; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INTERVIEWS; MIDDLE AGED; PAIN MEASUREMENT; PEPTIDE HORMONES; PREMENOPAUSE; REFERENCE VALUES; SLEEP DISORDERS;

EID: 35348824254     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2007.01.024     Document Type: Article

References (28)

1. Wolfe F., Ross K., Anderson J., Russell I.J., and Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38 (1995) 19-28
2. Staines D.R. Is fibromyalgia an autoimmune disorder of endogenous vasoactive neuropeptides?. Med Hypotheses 62 (2004) 665-669
3. Pillemer S.R., Bradley L.A., Crofford L.J., Moldofsky H., and Chrousos G.P. The neuroscience and endocrinology of fibromyalgia. Arthritis Rheum 40 (1997) 1928-1939
4. Weigent D.A., Bradley L.A., Blalock J.E., and Alarcon G.S. Current concepts in the pathophysiology of abnormal pain perception in fibromyalgia. Am J Med Sci 315 (1998) 405-412
5. Crofford L.J. Neuroendocrine abnormalities in fibromyalgia and related disorders. Am J Med Sci 315 (1998) 359-366
6. Harding S.M. Sleep in fibromyalgia patients: subjective and objective findings. Am J Med Sci 315 (1998) 367-376
7. Florini J.R., Printz P.N., Vitiello M.L., and Hintz R.L. Somatomedin-C levels in healthy young and old men: relationship to peak and 24-hour integrated levels of growth hormone. J Gerontol 40 (1985) 2-7
8. Bennett R.M., Cook D.M., Clark S.R., Burckhardt C.S., and Campbell S.M. Hypothalamic-pituitary-insulin-like growth factor-I axis dysfunction in patients with fibromyalgia. J Rheumatol 24 (1997) 1384-1389
9. Berwaerts J., Moorkens G., and Abs R. Secretion of growth hormone in patients with chronic fatigue syndrome. Growth Horm IGF Res 8 (1998) 127-129
10. Leal-Cerro A., Povedano J., Astorga R., Gonzalez M., Silva H., Garcia-Pasquera F., et al. The growth hormone (GH)-releasing hormone-GH-insulin-like growth factor-1 axis in patients with fibromyalgia syndrome. J Clin Endocrinol Metab 84 (1999) 3378-3381
11. Paiva E.S., Deodhar A., Jones K.D., and Bennett R. Impaired growth hormone secretion in fibromyalgia patients. Evidence for augmented hypothalamic somatostatin tone. Arthritis Rheum 46 (2002) 1344-1350
12. Jacobsen S., Main K., Danneskiold-Samsoe B., and Skakkebaek N.E. A controlled study on serum insulin-like growth factor-I and urinary excretion of growth hormone in fibromyalgia. J Rheumatol 22 (1995) 1138-1140
13. Buchwald D., Umali J., and Stene M. Insulin-like growth factor-I (somatomedin-C) levels in chronic fatigue syndrome and fibromyalgia. J Rheumatol 23 (1996) 739-741
14. McCall-Hosenfeld J.S., Goldenberg D.L., Hurwitz S., and Adler G.K. Growth hormone and insulin-like growth factor-1 concentrations in women with fibromyalgia. J Rheumatol 30 (2003) 809-814
15. Valkeinen H., Hakkinen K., Pakarinen A., Hannonen P., Hakkinen A., Airaksinen O., et al. Muscle hypertrophy, strength development, and serum hormones during strength training in elderly women with fibromyalgia. Scand J Rheumatol 34 (2005) 309-314
16. Denko C.W., and Malemud C.J. Serum growth hormone and insulin but not insulin-like growth factor-1 levels are elevated in patients with fibromyalgia syndrome. Rheumatol Int 25 (2005) 146-151
17. Camina J.P., Carreira M.C., Micic D., Pombo M., Kelestimur F., Dieguez C., et al. Regulation of ghrelin secretion and action. Endocrine 22 (2003) 5-12
18. Janssen J.A., van der Toorn F.M., Hofland L.J., van Koetsveld P., Broglio F., Ghigo E., et al. Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy. Eur J Endocrinol 145 (2001) 711-716
19. Barkan A.L., Dimaraki E.V., Jessup S.K., Symons K.V., Ermolenko M., and Jaffe C.A. Ghrelin secretion in humans is sexually dimorphic, suppressed by somatostatin, and not affected by the ambient growth hormone levels. J Clin Endocrinol Metab 88 (2003) 2180-2184
20. Otero M., Nogueiras R., Lago F., Meijide J., Amarelo J., Mera A., et al. Ghrelin plasmatic levels in patients with fibromyalgia. Rheumatol Int 25 (2005) 6-8
21. Hisli N. Beck Depresyon Olcegi'nin bir Turk örnekleminde geçerlilik ve güvenirliliǧi (The reliability and validity study of the beck depression inventory in a Turkish sample). Psikoloji Dergisi 6 (1988) 118-122 (In Turkish)
22. Burckhardt C.S., Clark S.R., and Bennett R.M. The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18 (1991) 728-733
23. Sarmer S., Ergin S., and Yavuzer G. The validity and reliability of the Turkish version of the fibromyalgia impact questionnaire. Rheumatol Int 20 (2000) 9-12
24. Bennett R.M., Clark S.C., and Walczyk J. A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia. Am J Med 3 (1998) 227-231
25. Denko C.W., and Boja B. Growth hormone, insulin, and insulin-like growth factor-I in hypermobility syndrome. J Rheumatol 28 (2001) 1666-1669
26. Denko C.W., Boja B., and Malemud C.J. Growth hormone and insulin-like growth factor-I in symptomatic and asymptomatic patients with diffuse idiopathic skeletal hyperostosis (DISH). Front Biosci 7 (2002) a37-a43
27. Norrelund H., Hansen T.K., Orskov H., Hosoda H., Kojima M., Kangawa K., et al. Ghrelin immunoreactivity in human plasma is suppressed by somatostatin. Clin Endocrinol 57 (2002) 539-546
28. Broglio F., van Koetsveld P., Benso A., Gottero C., Prodam F., Papotti M., et al. Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans. J Clin Endocrinol Metab 87 (2002) 4829-4832